Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hypoxia × gadobutrol × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 2 Carcinoma, Hepatocellular 2 Prostatic Neoplasms 1 Neuroendocrine Tumors 1 Neoplasms 1 Neoplasm Metastasis 1 Liver Neoplasms 1 Hypoxia 1 Digestive System Diseases 1 Colorectal Neoplasms 1 Breast Neoplasms 1

Interventions

3-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol 3 pimonidazole 2 TH 302 2 gadobutrol 1 fluoromisonidazole 1 Tirapazamine 1 Surgical Procedures, Operative 1 Radiotherapy 1 Propofol 1 Pancreaticoduodenectomy 1 Ipilimumab 1 Injections 1 Gemcitabine 1 Ethiodized Oil 1 Blood Specimen Collection 1 Biopsy 1 4-methylbenzenesulfonic acid 1 3-(4-(2-fluoroethoxy)phenyl)-2-(3-methyl-2-(4-((2-sulfamoylbenzo(d)thiazol-6-yloxy)methyl)-1H-1,2,3-triazol-1-yl)butanamido)propanoic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01989000 2018-06-27

MIPA

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase NA Completed

Gastrointestinal

Hypoxia, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡